⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 2, 2014Drug Delivery

A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma

Neil U. Barua Kirsten Hopkins Max Woolley Stephen O’Sullivan Rob Harrison Richard Edwards Alison Bienemann Marcella Wyatt Azeem Arshad Steven S. Gill

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Reduction in the volume of tumor enhancement indicates that intermittent CED of carboplatin has the potential to improve outcomes in glioblastoma. The novel technology described in this report make intermittent CED infusion regimes an achievable treatment strategy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Barua et al. (2014) studied this question.

synapsesocial.com/papers/69dbe50978a3e0e288685f6e https://doi.org/10.3109/10717544.2014.908248

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Convection-enhanced delivery of macromolecules in the brain.Original Research · 1994 · 1,418 citations
2Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyRCT · 2010 · 433 citations
3Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of TopotecanCohort Study · 2011 · 157 citations
4High-dose Carboplatin in Combination with Etoposide (JET Regimen) for Childhood Brain TumorsOriginal Research · 1990 · 64 citations
5AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiformePrognostic Study · 2011 · 195 citations
6Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced deliveryOriginal Research · 2011 · 23 citations
7A Phase 1–2 Trial of Superselective Carboplatin, Low-Dose Infusional 5-Fluorouracil and Concurrent Radiation for High-Grade GliomasEarly-Phase Clinical Trial · 1995 · 30 citations
8Distinct Responses of Xenografted Gliomas to Different Alkylating Agents Are Related to Histology and Genetic AlterationsOriginal Research · 2004 · 32 citations
9Rational design of inhaled antibacterials targeting alveolar macrophages for efficient killing of resistant bacteria associated with lower respiratory tract infections (LRTIs)Drug Delivery · 2026
10Exploration of various administration routes for the nitric oxide donating organic nitrite, nitrosooxypropanol, in a porcine modelDrug Delivery · 2026

More from Drug Delivery

More from University of Bristol

More from At Bristol

More from Frenchay Hospital

More from Renishaw (United Kingdom)